Expression of E-cadherin transcriptional regulators in ovarian carcinoma

被引:96
作者
Elloul, Sivan
Silins, Ilvars
Trope, Claes G.
Benshushan, Avi
Davidson, Ben [1 ]
Reich, Reuven
机构
[1] Univ Oslo, Natl Hosp, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel
[3] Univ Oslo, Natl Hosp, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
[4] Hebrew Univ Jerusalem, Sch Pharm, Fac Med, Dept Pharmacol & Expt Therapeut, IL-91120 Jerusalem, Israel
关键词
ovarian carcinoma; E-cadherin; transcriptional repressors;
D O I
10.1007/s00428-006-0274-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Unlike most epithelial cancers, E-cadherin expression is upregulated in ovarian carcinoma effusions compared with corresponding primary tumors. In the present study, we analyzed the anatomic site-specific expression of transcription factors that negatively regulate E-cadherin in ovarian carcinoma. Using reverse-transcription polymerase chain reaction, mRNA in situ hybridization, and Western blotting, we analyzed the expression and localization of the Snail, Slug, and SIP1 transcription factors and E-cadherin in 78 effusions, 41 primary carcinomas, and 15 solid metastases. Slug mRNA and protein expression was highest in metastases (p=0.042 and p < 0.001, respectively). Snail mRNA was comparable at all anatomic sites, but higher protein expression was found in primary tumors and solid metastases compared with effusions (p < 0.001). SIP1 mRNA expression was higher in effusions (p < 0.001) compared to other sites. Confocal microscopy analysis of fresh and cultured cells from effusion specimens revealed cytoplasmic localization of the Snail protein in primary tumor cells, with a nuclear shift following culturing of these cells. In conclusion, E-cadherin and its negative regulators show site-dependent expression in ovarian carcinoma. In solid tumors, E-cadherin is negatively regulated by Snail and Slug. In effusions, SIP1 may be the main regulator of E-cadherin, but with a lesser level of suppression compared with primary tumors and solid metastases.
引用
收藏
页码:520 / 528
页数:9
相关论文
共 35 条
[1]   The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells [J].
Batlle, E ;
Sancho, E ;
Franci, C ;
Domínguez, D ;
Monfar, M ;
Baulida, J ;
de Herreros, AG .
NATURE CELL BIOLOGY, 2000, 2 (02) :84-89
[2]   The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors [J].
Bolós, V ;
Peinado, H ;
Pérez-Moreno, MA ;
Fraga, MF ;
Esteller, M ;
Cano, A .
JOURNAL OF CELL SCIENCE, 2003, 116 (03) :499-511
[3]  
Bukholm IK, 2000, J PATHOL, V190, P15
[4]   Cell adhesion and signalling by cadherins and Ig-CAMs in cancer [J].
Cavallaro, U ;
Christofori, G .
NATURE REVIEWS CANCER, 2004, 4 (02) :118-132
[5]   The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion [J].
Comijn, J ;
Berx, G ;
Vermassen, P ;
Verschueren, K ;
van Grunsven, L ;
Bruyneel, E ;
Mareel, M ;
Huylebroeck, D ;
van Roy, F .
MOLECULAR CELL, 2001, 7 (06) :1267-1278
[6]   High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma [J].
Davidson, B ;
Goldberg, I ;
Gotlieb, WH ;
Kopolovic, J ;
Ben-Baruch, G ;
Nesland, JM ;
Berner, A ;
Bryne, M ;
Reich, R .
CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (10) :799-808
[7]   Malignant effusions: From diagnosis to biology [J].
Davidson, B .
DIAGNOSTIC CYTOPATHOLOGY, 2004, 31 (04) :246-254
[8]   Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis [J].
Davidson, B ;
Risberg, B ;
Reich, R ;
Berner, A .
CLINICS IN LABORATORY MEDICINE, 2003, 23 (03) :729-+
[9]  
Davidson B, 2000, J PATHOL, V192, P460
[10]   Snail, slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma [J].
Elloul, S ;
Elstrand, MB ;
Nesland, JM ;
Tropé, CG ;
Kvalheim, G ;
Goldberg, I ;
Reich, R ;
Davidson, B .
CANCER, 2005, 103 (08) :1631-1643